Contribution of GD2 ganglioside to aggressivness of human cholangiocarcinoma - Université de Rennes Accéder directement au contenu
Communication Dans Un Congrès Année : 2023

Contribution of GD2 ganglioside to aggressivness of human cholangiocarcinoma

Fichier non déposé

Dates et versions

hal-04266617 , version 1 (31-10-2023)

Identifiants

Citer

A. Mannini, C. Raggi, M. Correnti, E. Rovida, M. Aureli, et al.. Contribution of GD2 ganglioside to aggressivness of human cholangiocarcinoma. 55th Annual Meeting of the Italian Association for the Study of the Liver, Mar 2023, Roma, Italy. pp.S43, ⟨10.1016/j.dld.2023.01.084⟩. ⟨hal-04266617⟩
19 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Mastodon Facebook X LinkedIn More